Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Cream 1% Equivalence Study in Rosacea
NCT02840461Phase 3Completed
- Sponsor
- Allergan
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in papulopustular rosacea, sponsored by Allergan. Started Jun 2016; status: completed.
02
Drugs
ivermectin
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02840461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02840461.